Medical weight loss is structured clinical care, not a prescription in isolation. It combines assessment, nutrition, activity, behaviour change and, when appropriate, treatment with ongoing review.
Medical weight loss is a clinician-led approach to improving weight and the health problems connected with it. It should combine a proper assessment, a realistic nutrition and activity plan, behaviour-change support and regular review. Prescription treatment may be one part of that plan when it is clinically appropriate; it is not the whole plan.
For men, good care should look beyond the number on the scales. Waist size, blood pressure, metabolic health, sleep, physical function, muscle, sexual health and symptoms that may need separate investigation can all matter.
Medical weight loss is structured healthcare for adults living with overweight or obesity. It is designed for people whose weight is affecting their health, or whose previous attempts have not produced a result they can maintain.
It may include:
Assessment should identify the factors affecting the individual and select the least burdensome approach likely to improve his health. A uniform programme will not suit every patient.
An assessment may be useful if:
Seeking an assessment does not commit you to medication. It should help determine whether active weight loss is appropriate now, what risks need attention, and what level of support is justified.
A clinician should ask how your weight has changed over time, what you have tried, what helped, what was unsustainable, and what you want to improve. Better mobility, sleep, blood pressure, fertility planning or physical performance may be more meaningful goals than a single target weight.
BMI is a practical screening measure, but it does not directly measure body fat or show where fat is stored. It can also be misleading in people with high muscle mass.
For adults with a BMI below 35 kg/m², NICE recommends using waist-to-height ratio alongside BMI as an estimate of central adiposity. A simple public-health message is to keep waist circumference below half of height. Ethnic background also matters because cardiometabolic risk can occur at lower BMI thresholds in some groups. NICE assessment guidance
These measurements are starting points, not a diagnosis on their own.
The assessment should consider blood pressure, glucose regulation, cholesterol, liver health, sleep apnoea, cardiovascular disease, joint limitations, mental health, disordered eating and any other relevant condition.
Current medicines matter too. Some can influence appetite or weight; others may need closer monitoring when food intake or weight changes. Identified conditions should be managed in parallel rather than left untreated until weight has fallen.
Men may present with fatigue, reduced exercise tolerance, poor sleep, erectile difficulties, reduced libido or fertility concerns at the same time as weight gain. These symptoms deserve their own clinical assessment. They should not automatically be labelled as a consequence of weight, and they do not by themselves prove a hormone problem.
Where symptoms, examination or history justify it, a clinician may investigate an endocrine, metabolic, sleep or reproductive cause. The purpose of testing is to answer a clinical question and change management—not to order the same panel for everyone.
A weight-management plan should reflect what you currently eat, your cooking and work patterns, food access, alcohol intake, physical activity, injuries and training history.
Function matters. Baseline measures might include walking tolerance, a simple strength measure or the activities you can and cannot perform comfortably. This is particularly important when preserving muscle is a priority.
An effective plan should create a sustainable energy deficit without making the diet nutritionally inadequate. It may focus on meal structure, portions, protein and fibre-rich foods, drinks, alcohol, food environment, emotional triggers and planning for predictable difficult situations.
The best approach is one the patient can continue. Rigid rules are rarely useful if they collapse during work travel, family commitments or social occasions.
Physical activity improves health even when the scales change slowly. The 2026 UK Chief Medical Officers' guidance recommends activity every day where possible, strength work for the major muscle groups on at least two days each week, and a weekly total of at least 150 minutes of moderate activity or the vigorous equivalent. People who are inactive can still gain meaningful benefits from starting below those levels and building gradually. UK physical activity guidelines
For men who are dieting or using appetite-reducing treatment, resistance exercise has an additional role: helping protect strength and lean tissue.
Weight-management medicines act through different mechanisms, including appetite and satiety pathways or reduced absorption of dietary fat. They are prescription treatments with eligibility criteria, contraindications and side effects. Different products are licensed for different uses; a medicine licensed for diabetes is not automatically licensed for weight management.
In the UK, prescription treatment must follow a consultation with an authorised healthcare professional. The MHRA advises patients to obtain these medicines only from a legitimate pharmacy with a prescription and warns against social-media sellers, salons and unregulated products. MHRA guidance for GLP-1 medicines
NICE recommends using weight-management medicines alongside a reduced-calorie diet and increased physical activity, with regular review of effect, adherence and behavioural support. NICE medicines guidance
Some people need a multidisciplinary specialist service. Bariatric surgery may be appropriate for selected patients after a comprehensive assessment of benefits, risks, nutrition, psychological factors and long-term follow-up needs. It is not a shortcut or an interchangeable alternative to every other treatment.
A safe service should:
If a website appears to offer prescription medicine without a meaningful consultation, treats a form as an automatic approval, or encourages you to buy from an unregulated source, that is a reason to stop.
Body weight is useful, but it should not be the only outcome. Depending on the patient, review may include:
Day-to-day weight fluctuates. A trend measured under reasonably consistent conditions is more informative than one isolated reading.
Active weight loss may need to wait or be modified if there is an untreated eating disorder, significant nutritional risk, an unstable medical problem, unexplained weight change, a relevant contraindication, or another clinical priority.
Pregnancy and breastfeeding require specific advice, and prescription treatments have different requirements before conception. Although this guide is written for men, fertility planning still matters: men should tell their clinician about plans to conceive, relevant sexual or reproductive symptoms, and any other medicines or hormones they use.
Medical weight loss should be a pathway, not a transaction. Heracles' role is to establish what is driving risk, decide whether treatment is appropriate, protect health and function during weight loss, and connect care across men's endocrine, metabolic, sexual and reproductive health when that connection is clinically relevant.
Yes, if registered clinicians and pharmacy partners provide a meaningful assessment, appropriate prescribing, follow-up and a clear route to help. Check the pharmacy's registration.
